Key Highlights
- Medable Inc. announces a strategic partnership with Pluto Health, combining their technological solutions to enhance patient experience and data management in clinical trials.
- The collaboration aims to streamline patient enrollment and retention, facilitate recruitment and monitoring, and improve data quality in clinical trials.
- Patients will gain more control and the ability to share their health data directly into clinical trials through a seamless integration, enhancing their overall experience and engagement.
- Clinical research sites will benefit from a digitized screening process, while trial sponsors will enhance cost efficiency and expedite study execution.
- The partnership will also ease the access to relevant patient information for study teams and facilitate long-term follow-up with patients post-trial.
Source: Business Wire
Notable Quotes
- “Our partnership is primarily a win for patients, alongside other stakeholders, who will benefit from ongoing enhanced support.” – Dr. Joy Bhosai, CEO & Founder of Pluto Health
- “Together, our organizations will leverage advanced technologies to reduce inefficiencies from trial execution and deliver better site and patient experiences while expanding access to clinical research to more patients when they need it most.” – Dr. Michelle Longmire, CEO & Co-Founder of Medable
SoH's Take
The strategic partnership between Medable and Pluto Health marks a pivotal moment in the realm of clinical trials, promising to bring forth a seamless integration of technologies that will enhance patient experiences and improve data management. By amalgamating Medable’s digitally enabled clinical trials platform and Pluto Health’s health coordination platform, the partnership is poised to tackle some of the most pressing challenges in clinical trials, such as patient enrollment, retention, and data quality. Particularly noteworthy is the potential to empower patients with greater control over their health data and the ability to share it directly into clinical trials, which not only enhances their experience but also promises to streamline processes for clinical research sites and trial sponsors. This collaboration is anticipated to pave the way for more efficient, patient-centric, and data-driven clinical trials, potentially setting a new benchmark in the industry.
